This week, and for the foreseeable future, we're committed to sharing the most updated reliable information on COVID-19 and MS.

Joining me as my guest is Dr. Aaron Miller. Dr. Miller is the Chair of the Society’s National Medical Advisory Committee and is also the Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis and a Professor of Neurology at the Icahn School of Medicine at Mount Sinai.  He also serves as Vice-Chair for Education in the Department of Neurology.  Dr. Miller was the first Chairman of the multiple sclerosis section of the American Academy of Neurology and he's participated in numerous clinical trials of new MS treatments. 

We're talking with Dr. Miller about the National MS Society's guidance for MS disease-modifying therapies and the coronavirus (COVID-19), whether you should hold off starting a new disease-modifying therapy, whether you have to take additional precautions surrounding the other medications you might be using to manage MS symptoms, whether COVID-19 can cause an MS relapse, and more.

 

 

We're also talking about the MS Society's new Ask An MS Expert webinar series that we're hosting. We'll tell you about the Families First Coronavirus Response Act that was signed into law last week, and how it might affect you and your family.

We're sharing news about a study that shows that women require fewer MS-related hospitalizations as they age. We'll tell you how virtual reality can reduce the risk of falls by predicting balance issues among people with MS before they, themselves, become aware that they might have balance issues. And Janssen, a division of Johnson & Johnson, has applied for FDA approval of a disease-modifying therapy for relapsing forms of MS.

We have a lot to talk about! Are you ready for RealTalk MS??! ___________   Welcome to the New Normal  :18   Introducing the National MS Society's Ask an MS Expert Webinar Series  :32   Make sure you're getting your COVID-19 info from credible sources   3:47

COVID-19 on the National MS Society's Website  4:58

The Families First Coronavirus Response Act Signed Into Law  5:47

Study Finds Fewer MS-Related Hospitalizations As Women Age  7:46

Study Uses Virtual Reality To Detect Balance Issues In MS   10:59

Janssen Submits Application for FDA Approval of Ponesimod  13:47

My Interview with Dr. Aaron Miller  14:51

Share this Episode  24:32

Reminder...Please Donate to Walk-MS  25:05

___________

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/134

___________

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes.

Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: [email protected]Phone: (310) 526-2283

___________

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

National MS Society's Ask an MS Expert Webinar: What You Need to Know About MS & COVID-19 with Dr. Aaron Miller and Kathy Costello

What You Need to Know About Coronavirus (COVID-19)

MS Disease-Modifying Treatment Guidelines for Coronavirus (COVID-19)

Predictors of Hospitalization in a Canadian MS Population: A Matched Cohort Study

Can Optical Flow Perturbations Detect Walking Balance Impairment in People with Multiple Sclerosis?

Jon's WALK-MS Fundraising Page

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating & Review

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 134 Hosted By: Jon Strum Guests: Dr. Aaron Miller

Tags: MS, MultipleSclerosis, MSResearch, MSActivist, MSSociety, Coronavirus, COVID19, RealTalkMS

Privacy Policy